A Randomized Study of JS004 and Toripalimab Combined With Chemotherapy vs Toripalimab Combined With Chemotherapy vs Chemotherapy Alone as Neoadjuvant Therapy for Stage II-III Triple-negative Breast Cancer (TNBC).

Clinical trial NCT07101614 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07101614
Sponsor: Shengjing Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

TNBC - Triple-Negative Breast Cancer

Start date: 2025-09-01
Primary completion: 2027-11-30
Enrollment: 125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.